We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Genomics Market Report:Market Segmentation By Product Type, By Technology, By Application, By End User With COVID-19 impact | Forecast Period 2017-2030

Published Date :

2020-05-15

Report Pages :

879

Format :

PDF

Region Covered :

Global

Market Overview                            

The clinical applications of genomic technologies are vast and offer opportunities to improve healthcare across the breadth of medical specialties like gene discovery and diagnosis of rare monogenic disorders, identification and diagnosis of genetic factors contributing to common disease, pharmacogenetics and targeted therapy, prenatal diagnosis and testing, infectious diseases, personalized medicine, etc. CRISPR is the newest and efficient with accurate method to edit a cell’s genome. However, as it opens up a myriad of wonderful opportunities as well as frightening ethical challenges in healthcare, there are already numerous start-ups experimenting with it and in 2016, CRISPR even got a green light for clinical trials from the US National Institutes of Health. In the future, it might become the ultimate weapon against cancer, malaria or genetic disorders.

Goldstein Intelligence Market analyst forecast the genomics market size is set to grow at a CAGR of 11.2% over the forecast years of 2017-2030. Intensifying level of competition in the global healthcare industry, increased demand for genetically modified animals and plants and the constantly reducing prices of genetic procedures are expected to lead to vast traction to the global genomics market in the future.

Genomics Market Segmentation

By Product Type

  • Instruments
  • Consumables
  • Services

By Technology

  • Microarray Technology
  • PCR
  • DNA Sequencing
  • Nucleic Acid Extraction & Purification
  • Others (Gene Expression, etc)

By Application

  • Diagnostics (Prenatal diagnosis and testing)
  • Infectious diseases
  • Pharmacogenetics and targeted therapy
  • Personalized Medicines
  • Gene Therapy
  • Genome Editing
  • Agriculture Research
  • Others (Marine Research, biofuels, and coal mines)

By End User

  • Hospitals & Clinics
  • Research & Development Centers
  • Pharmaceutical and Biotechnology Companies
  • Agri-genomics organizations

Based on Geography

  • North America (U.S. & Canada)  Genomics Market {Market Share (%), Market Size (USD Billion)}
  • Latin America (Brazil, Mexico, Argentina & Rest of Latin America)  Genomics Market {Market Share (%), Market Size (USD Billion)}
  • Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE)  Genomics Market {Market Share (%), Market Size (USD Billion)}
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia)  Genomics Market {Market Share (%), Market Size (USD Billion)}
  • Middle East & Africa (GCC, South Africa, North Africa, RoMEA)  Genomics Market {Market Share (%), Market Size (USD Billion)}

Revenue Share by Application & by Region

Based on application, diagnostics application market dominated the overall genomics market in terms of market share in 2017 at over 32.5% due to accuracy of gene-based diagnostics of variable diseases. Personalized medicine market is expected to grow at the highest CAGR of 11.42% during the forecast period due to profound focus of creating medicines for cancer patients where effectiveness has been proved to be higher as compared to other therapies.

Based on geography, Europe accounted for the largest share of the overall genomics market in 2017 at over 37.25%. While APAC is expected to witness the most significant development owing to strengthening economies of developing countries such as India and China and the increased focus of the respective governments on encouraging research in the field of genomics, in addition, China hosts the world’s largest genomic research institute, the Beijing Genomics Institute in order to sustain the growth of genomics market. North America genomics market will grow at the substantial rate due to the ample amount of funds and presence of companies undertaking research in the field of genomics.  

Trends, Drivers & Challenegs to Market Growth

According to our global market study on the basis of extensive primary and secondary research: “One trend is digital genome, an emerging technology that can sequence and digitize the whole genome in minutes and at the cost of only a few hundred dollars with an additional ability to rapidly and cheaply determine an individual unique genetic make-up promises a revolution in more personalized and effective healthcare. Results can be delivered to your laptop on a USB stick and easily shared via the internet.”

According to the report, major driving factor is the adoption of genome editing/genome engineering in genomics which are used for cell line engineering, genetic engineering, diagnostics and therapeutics.  For instance, genome editing is used in target gene modification in plants and eradication of vector borne diseases such as yellow fever, dengue, Zika, West Nile, Schistomiasis, Leishmaniasis and Lymes disease which is the segment that is attracting major portion of investments in agricultural and healthcare sector.  

Further, the report states the biggest challenge is the complex nature of the drugs coupled with high development costs, sub-optimal development framework and inter-patient variability of effects contributing to potential barriers that are integrating genomics into underserved medical settings.

 Covered In This Global Genomics Market Report                         

The report covers the present ground scenario and the future growth prospects of the genomics market for 2017-2030 along with the data of installed units, consumables and services in medical facilities worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The genomics market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new e

ntrants along with detailed value chain analysis.

 Global Genomics Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Genomics market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Genomics market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

COVID-19 imapct on "Global Genomics Market "    

Impact of COVID-19 Outbreak on “Global Genomics Market ”, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Global Genomics Market . It also showcases the expected recovery schedule and losses in the industry and other various major factors.

Key Market Players

Our global Genomics market report comprises of the following companies as the key players.

  • Bayer AG
  •  Affymetrix Inc.
  •  Agilent Technologies, Inc.
  •  Genomatix Software Inc.
  •  Navigenics, Inc.
  •  Roche Diagnostics
  •  Myriad Genetics, Inc.
  • QIAGEN, Inc.
  •  Illumina, Inc.
  •  GE Healthcare
  •  Thermo Fisher Scientific
  •  Eurofins Scientific
  •  BGI
  •   Bio-Rad Laboratories
  •  Oxford Nanopore Technologies
  •  Pacific Biosciences of California
  • Eppendorf.

Other key vendors are: 23andme, Futura Genetics, Veritas Genetics, Counsyl, Verge Genomics, Deep Genomics, IBM Watson for Genomics, Verily Life Sciences, DeCODE, Foundation Medicine, Rosetta Genomics, Color Genomics, Quest Diagnostics, National Geographic’s ancestry test, Ancestry, Illumina, Nanopore Technologies, Edico Genome, BGI, Intellia Therapeutics, Editas Medicine, CRISPR Therapeutics and MyDNA.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send here request for market report sample.

Intended Audience

  • Genomics products and services companies and distributors
  • Genomics instrument and consumables manufacturers and suppliers
  • In–licensing life sciences companies (pharmaceutical/biopharmaceutical/biotechnology)
  • Out–licensing life science company (pharmaceutical/biopharmaceutical/biotechnology)
  • Genomics research organizations
  • Academic institutes
  • Government and private research institutes
  • Medical research centers
  • Public and private health agencies
  • Genomics and biotechnology associations
  • Business consultancies
  • Venture capitalists

Key questions answered in this market study

  • What is the total market size by 2030 and what would be the expected growth rate of market?
  • What is the revenue of total market in 2017-18 and what would be the expected demand over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.




{ }

Global Genomics Market Report:Market Segmentation By Product Type, By Technology, By Application, By End User With COVID-19 impact | Forecast Period 2017-2030

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

Please Select Linenece Type